These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1857478

  • 1. Effects of dipyridamole on the short-term evolution of glomerulonephritis.
    Camara S, de la Cruz JP, Frutos MA, Sanchez P, Lopez de Novales E, Sanchez E, Sanchez de la Cuesta F.
    Nephron; 1991; 58(1):13-6. PubMed ID: 1857478
    [Abstract] [Full Text] [Related]

  • 2. Effect of dipyridamole treatment on proteinuria in pediatric renal disease.
    Ueda N, Kawaguchi S, Niinomi Y, Nonoda T, Ohnishi M, Ito S, Yasaki T.
    Nephron; 1986; 44(3):174-9. PubMed ID: 3785481
    [Abstract] [Full Text] [Related]

  • 3. Clinical effect of dipyridamole in patients with IgA nephropathy.
    Yagame M, Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
    [Abstract] [Full Text] [Related]

  • 4. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 5. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH.
    N Engl J Med; 1984 May 31; 310(22):1421-6. PubMed ID: 6371535
    [Abstract] [Full Text] [Related]

  • 6. Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
    Izumino K, Iida H, Asaka M, Mizumura Y, Sasayama S.
    Nephron; 1986 May 31; 43(1):56-61. PubMed ID: 2939358
    [Abstract] [Full Text] [Related]

  • 7. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Shindo T, Tetsutani T, Yamamoto T, Okubo H, Oka G.
    Arzneimittelforschung; 1982 May 31; 32(3):301-9. PubMed ID: 7200790
    [No Abstract] [Full Text] [Related]

  • 8. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1992 May 31; 37(5):229-34. PubMed ID: 1606772
    [Abstract] [Full Text] [Related]

  • 9. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents.
    Cattell V, Mehotra A.
    Br J Exp Pathol; 1980 Jun 31; 61(3):310-4. PubMed ID: 7000132
    [Abstract] [Full Text] [Related]

  • 10. [The efficacy of using antiaggregants in chronic glomerulonephritis with grade-I chronic kidney failure].
    Kolesnyk MO, Lapchyns'ka II.
    Lik Sprava; 1996 Jun 31; (1-2):135-7. PubMed ID: 9005074
    [Abstract] [Full Text] [Related]

  • 11. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec 31; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 12. Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
    Kalowski S, Kincaid-Smith P.
    Med J Aust; 1973 Jul 28; 2(4):164-6. PubMed ID: 4741342
    [No Abstract] [Full Text] [Related]

  • 13. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 Jul 28; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

  • 14. [The efficacy of kurantil and its effect on thrombocytic hemostasis in patients with chronic glomerulonephritis].
    Kolesnyk MO, Lapchyns'ka II, Bielyts'ka HO.
    Lik Sprava; 1994 Jul 28; (9-12):145-8. PubMed ID: 7604556
    [Abstract] [Full Text] [Related]

  • 15. Antiproteinuric effect of indomethacin and dipyridamole in various glomerulopathies of adults.
    Banerjee S, Sharma VK, Pareek SK, Ratnu KS.
    J Assoc Physicians India; 1985 Nov 28; 33(11):716-7. PubMed ID: 4093385
    [No Abstract] [Full Text] [Related]

  • 16. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 28; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 17. Dipyridamole in the nephritides.
    Wardle EN.
    Am J Ther; 1998 Mar 28; 5(2):107-9. PubMed ID: 10099046
    [Abstract] [Full Text] [Related]

  • 18. [Glomerulonephritis and anticoagulants: therapy with dipyridamole in lupoid glomerulonephritis].
    Barlattani M, Guglielmi G, Mammarella A.
    Clin Ter; 1972 Nov 15; 63(3):251-7. PubMed ID: 4644529
    [No Abstract] [Full Text] [Related]

  • 19. Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: a controlled study.
    Laurent J, Belghiti D, Bruneau C, Lagrue G.
    Am J Nephrol; 1987 Nov 15; 7(3):198-202. PubMed ID: 3307414
    [Abstract] [Full Text] [Related]

  • 20. Effect of anti-platelet agents on circulating platelet aggregates in patients with glomerulonephritis.
    Woo KT, Whitworth JA, Kincaid-Smith P.
    Thromb Res; 1987 Nov 15; 20(5-6):663-8. PubMed ID: 7233389
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.